Llwytho...
WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Eur J Hum Genet |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350592/ https://ncbi.nlm.nih.gov/pubmed/24327189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.275 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|